pancreatic cancer semaglutide Clinical Impact of Beyond Glycemic Control: A Critical Analysis of Oncogenic Potential and Mitigation of Cardiotoxicity GLP-1s appear to cut cancer

TRIUMPH-1 and Core Obesity Management The TRIUMPH-1 trial (NCT05929066) is investigating retatrutide in the broader population of adults with obesity or overweight without diabetes

New Self-Pay Pathways for Seamless Care What happens when a benefits strategy doesnt cover GLP-1s

With almost five years of experience working in the medical field, Bernabe is no stranger to the side effects of semaglutide injections

Discover the research Description BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a partial sequence of human gastric juice protein

These bioactive compounds are rich in electron-dense sulfur atoms, which have a natural, high affinity for toxic heavy metal ions

Theyre high in polyphenols, which can help fight inflammation and cell damage